Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abcellera Biologics Inc (NQ: ABCL )

6.990 +0.190 (+2.79%)
Streaming Delayed Price Updated: 10:11 AM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 371,928
Open 6.920
Bid (Size) 6.990 (6)
Ask (Size) 7.000 (9)
Prev. Close 6.800
Today's Range 6.860 - 7.140
52wk Range 5.530 - 14.97
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
From AbCellera Biologics Inc.
Via Business Wire

Performance

YTD
-26.34%
-26.34%
1 Month
+3.25%
+3.25%
3 Month
-17.08%
-17.08%
6 Month
-48.45%
-48.45%
1 Year
-8.27%
-8.27%

More News

Read More
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
7 Growth Stocks That Could Double Your Money in 2023
Via InvestorPlace
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Recap: AbCellera Biologics Q1 Earnings
Via Benzinga
AbCellera Reports Q1 2023 Business Results
From AbCellera Biologics Inc.
Via Business Wire
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies
Via The Motley Fool
4 Analysts Have This to Say About AbCellera Biologics
Via Benzinga
Preview: AbCellera Biologics's Earnings
Via Benzinga
7 Stocks Under $10 That Analysts Love
Via InvestorPlace
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy
Via The Motley Fool
7 Best Stocks Under $10 to Buy in April
Via InvestorPlace
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
From AbCellera Biologics Inc.
Via Business Wire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Via InvestorPlace
7 Stocks to Bet On if You Want to Be Richer Than Elon Musk
Via InvestorPlace
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Via Benzinga
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript
Via The Motley Fool
AbCellera Reports Full Year 2022 Business Results
From AbCellera Biologics Inc.
Via Business Wire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.